The role of biomarkers in the early detection of sepsis

Explore how biomarkers can be utilized to aid the early detection of sepsis, in this presentation from the 2024 World Sepsis Congress Spotlight: Unmet Need in Sepsis Diagnosis and Therapy. In this session, discover relevant biomarkers for use in low-resource settings, explore what different clinical phenotypes suggest, find out how a single host biomarker could reduce antibiotics in neonates with suspected LOS (Late-onset sepsis), and much more.

Time stamps for easy viewing:

00:00:00 Introduction
00:01:30 Andrew Argent, University Cape Town, South Africa – Biomarkers of Relevance in Low-Resource Settings 00:14:26 Rita Murri, Gemelli University of Rome, Italy – A Patient is Admitted at the Emergency: What to Do?
00:30:21 Chris Seymour, University of Pittsburgh, USA – Clinical Phenotypes: What Do They Suggest?
00:42:43 Evangelos Giamarellos-Bourboulis, European Sepsis Alliance, Greece – Biomarkers as Endpoints for Treatment Efficacy
00:59:32 Sylvie Pons, Joint Research Unit, Hospices Civils de Lyon, bioMérieux, France – Reducing Antibiotics With a Single Host Biomarker in Neonates Suspected of LOS: The EMERAUDE Study